Aerovate Therapeutics, Inc. (AVTE)
NASDAQ: AVTE · IEX Real-Time Price · USD
21.36
-1.14 (-5.07%)
Apr 18, 2024, 12:11 PM EDT - Market open
Aerovate Therapeutics Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for AVTE stock have an average target of 50, with a low estimate of 35 and a high estimate of 65. The average target predicts an increase of 134.08% from the current stock price of 21.36.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for AVTE stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 1 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Maintains $35 | Buy | Maintains | $35 | +63.86% | Apr 1, 2024 |
| Jefferies | Jefferies | Strong Buy Initiates $21 → $65 | Strong Buy | Initiates | $21 → $65 | +204.31% | Mar 25, 2024 |
| Guggenheim | Guggenheim | Strong Buy Initiates $36 | Strong Buy | Initiates | $36 | +68.54% | Mar 1, 2023 |
| BTIG | BTIG | Hold → Strong Buy Upgrades $27 | Hold → Strong Buy | Upgrades | $27 | +26.40% | Dec 6, 2022 |
| BTIG | BTIG | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Aug 16, 2022 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-3.08
from -2.87
EPS Next Year
-3.02
from -3.08
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | n/a | 42.8M | 141.6M | 339.6M |
| Avg | n/a | n/a | 12.9M | 68.3M | 170.5M |
| Low | n/a | n/a | n/a | n/a | 40.0M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | 995.7% | 397.2% |
| Avg | - | - | - | 428.4% | 149.6% |
| Low | - | - | - | - | -41.4% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -2.77 | -2.79 | -1.79 | -1.25 | 0.30 |
| Avg | -3.08 | -3.02 | -3.15 | -2.20 | -1.11 |
| Low | -3.35 | -3.20 | -3.54 | -3.07 | -2.42 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.